RNAC

Latest SEC Filings & News for RNAC

2 most recent filings and news items mentioning RNAC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RNAC/news?limit=20"

Pull RNAC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Earnings|Guidance|OfferingAug 6, 2026Positive

Cartesian reports Q2 2026 financials, funding to 2028

Cartesian Therapeutics reported Q2 2026 financials, noting a cash balance of roughly $149 million and a non-dilutive credit facility set to extend runway. The company updated on its Descartes-08 pipeline trials in myasthenia gravis, myositis, and juvenile dermatomyositis with sev

View filing at SEC.gov →

M&AJun 9, 2026Positive

Cartesian partners with WestGene to advance in vivo CAR-T therapies for autoimmune diseases

Cartesian Therapeutics announced a strategic licensing agreement with WestGene Biopharma to develop next-generation in vivo CAR-T treatments, combining WestGene's lipid nanoparticle platform with Cartesian's mRNA payload technology. A clinical trial is expected to begin in the se

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.